We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAI icon
2351
FTAI Aviation
FTAI
$22B
$399 ﹤0.01%
+3
New +$340
SBGI icon
2352
Sinclair Inc
SBGI
$974M
$398 ﹤0.01%
+26
New +$363
RUM icon
2353
RUM Group Inc
RUM
$1.67B
$397 ﹤0.01%
+74
New +$436
LSEA
2354
DELISTED
Landsea Homes
LSEA
$395 ﹤0.01%
+32
New +$365
HCKT icon
2355
Hackett Group
HCKT
$255M
$394 ﹤0.01%
+15
New +$376
CXT icon
2356
Crane NXT
CXT
$3.12B
$393 ﹤0.01%
+7
New +$407
STOK icon
2357
Stoke Therapeutics
STOK
$1.83B
$393 ﹤0.01%
+32
New +$453
DOCS icon
2358
Doximity
DOCS
$3.77B
$392 ﹤0.01%
+9
New +$300
BWFG icon
2359
Bankwell Financial Group
BWFG
$513M
$389 ﹤0.01%
+13
New +$356
EVC icon
2360
Entravision Communication
EVC
$1.02B
$389 ﹤0.01%
+188
New +$375
SCPH
2361
DELISTED
scPharmaceuticals
SCPH
$388 ﹤0.01%
+85
New +$411
CNDT icon
2362
Conduent
CNDT
$234M
$387 ﹤0.01%
+96
New +$352
AKYA
2363
DELISTED
Akoya BioSciences
AKYA
$386 ﹤0.01%
+142
New +$347
RWX icon
2364
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
$386 ﹤0.01%
+14
New +$367
ACAD icon
2365
Acadia Pharmaceuticals
ACAD
$4.35B
$385 ﹤0.01%
+25
New +$417
CCNE icon
2366
CNB Financial Corp
CCNE
$1.02B
$385 ﹤0.01%
+16
New +$373
KLTR icon
2367
Kaltura
KLTR
$220M
$384 ﹤0.01%
+282
New +$347
RDNW
2368
RideNow Group
RDNW
$251M
$383 ﹤0.01%
+80
New +$331
TNDM icon
2369
Tandem Diabetes Care
TNDM
$1.18B
$382 ﹤0.01%
+9
New +$382
CRMD icon
2370
CorMedix
CRMD
$596M
$380 ﹤0.01%
+47
New +$254
LAB icon
2371
Standard BioTools
LAB
$303M
$380 ﹤0.01%
+197
New +$386
WTBA icon
2372
West Bancorporation
WTBA
$472M
$380 ﹤0.01%
+20
New +$384
BTMD icon
2373
Biote Corp
BTMD
$70.7M
$379 ﹤0.01%
+68
New +$454
FG icon
2374
F&G Annuities & Life
FG
$3.93B
$378 ﹤0.01%
+8
New +$331
NHC icon
2375
National Healthcare
NHC
$3.53B
$377 ﹤0.01%
+3
New +$377

Similar funds

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.